Literature DB >> 29698861

LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.

Hongyu Ji1, Yu Liu1, Fang He1, Ran An2, Zhimin Du3.   

Abstract

Hyperlipidemia has been highlighted to be one of the most prominent and global chronic condition nowadays. Daming capsule (DMC), a traditional Chinese medicine (TCM) preparation, has treated hyperlipidemia on clinic in China for decades. Our recent study showed that aloe-emodin (AE) is one of the main bioactive components in DMC. Therefore, the present study aims to further investigate the lipid-lowering effect by serum biochemistry and histopathological examination, and reveal the underlying mechanisms by urinary metabolomics approach. After oral administration of AE for 6 weeks, the total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-c) levels in 50 and 100 mg/kg AE groups were both decreased significantly (P < 0.05 and P < 0.001). An ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry (UPLC-ESI-QTOF-MS) followed by principal components analysis (PCA), partial least squares- discriminant analysis (PLS-DA), orthogonal partial least squares-discriminant analysis (OPLS-DA), correlation analysis, heat map, and KEGG pathways was employed to identify 26 potential biomarkers. Twenty three among them were restored by AE including L-citrulline, 6-methylaminopurine, imidazoleacetic acid riboside, N-acetylhistamine, 3-methyladenine, 1-methyladenosine, dopamine, N1-methyl-4-pyridone-3-carboxamide, formylanthranilic acid, 4-pyridoxate, cAMP, salsolinol, isethionate, d-ribonic acid, 3-sulfolactic acid, vitamin C, mesaconic acid, sulfosalicylic acid, salicyluric acid, N-acetylanthranilic acid, 4,6- Dihydroxyquinoline, sebacic acid and hyocholic Acid. The related metabolic pathways include TCA cycle, the metabolism of amino acids, taurine, B vitamins, purines and pyrimidines. The results indicate that AE has a favorable therapeutic effect on HFD-induced hyperlipidemia by adjusting the metabolic disorders. Notably, urinary metabolomics combined with pattern recognition analysis provides a powerful and reliable approach into the research and development of TCM and phytochemicals.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aloe-emodin; Hyperlipidemia; OPLS-DA; UPLC-ESI-QTOF-MS; Urinary metabolomics

Mesh:

Substances:

Year:  2018        PMID: 29698861     DOI: 10.1016/j.jpba.2018.04.015

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Optimization of extraction parameters of Pleurotus eryngii polysaccharides and evaluation of the hypolipidemic effect.

Authors:  Yuanyuan Zhao; Xuefeng Chen; Yanni Zhao; Wei Jia; Xiangna Chang; Huan Liu; Ning Liu
Journal:  RSC Adv       Date:  2020-03-24       Impact factor: 4.036

Review 2.  Metabolomics biotechnology, applications, and future trends: a systematic review.

Authors:  Qiang Yang; Ai-Hua Zhang; Jian-Hua Miao; Hui Sun; Ying Han; Guang-Li Yan; Fang-Fang Wu; Xi-Jun Wang
Journal:  RSC Adv       Date:  2019-11-14       Impact factor: 4.036

Review 3.  Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases.

Authors:  Kai Wang; Yanhan Dong; Jing Liu; Lili Qian; Tao Wang; Xiangqian Gao; Kun Wang; Luyu Zhou
Journal:  Oxid Med Cell Longev       Date:  2020-11-17       Impact factor: 6.543

Review 4.  Innovative Application of Metabolomics on Bioactive Ingredients of Foods.

Authors:  Sumei Hu; Caiyu Liu; Xinqi Liu
Journal:  Foods       Date:  2022-09-23

5.  1,25(OH)2D3 improves blood lipid metabolism, liver function, and atherosclerosis by constraining the TGF-β/Smad signaling pathway in rats with hyperlipidemia.

Authors:  Chunpeng Lu; Yanping Yin; Yongliang Cui; Lili Wang; Yan Bai; Jian Li; Tingting Huang; Maimaiti Reziwanguli; Lifu Miao
Journal:  Cell Cycle       Date:  2019-09-23       Impact factor: 4.534

6.  UPLC-QTOF/MS-Based Lipidomic Profiling of Liver Qi-Stagnation and Spleen-Deficiency Syndrome in Patients with Hyperlipidemia.

Authors:  Piao Shenghua; Tan Shuyu; Li Kunping; Zhan Huixia; Xiao Xue; Guo Jiao
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-30       Impact factor: 2.629

Review 7.  Pharmacological Update Properties of Aloe Vera and its Major Active Constituents.

Authors:  Marta Sánchez; Elena González-Burgos; Irene Iglesias; M Pilar Gómez-Serranillos
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

8.  Discovering Temporal Patterns in Longitudinal Nontargeted Metabolomics Data via Group and Nuclear Norm Regularized Multivariate Regression.

Authors:  Zhaozhou Lin; Qiao Zhang; Shengyun Dai; Xiaoyan Gao
Journal:  Metabolites       Date:  2020-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.